(Q37934487)

English

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

scientific article published on 19 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Frédéric Lamoth

object named as

F Lamoth

2

0 references

Stéphane Bretagne

object named as

S Bretagne

6

0 references

author name string

O Marchetti

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

M Mikulska

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

C Viscoli

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

P Verweij

5

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups

7

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

language of work or name

0 references

publication date

19 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

846-854

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Disseminated cryptococcosis in HIV-uninfected patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Longitudinal study of cryptococcosis in adult solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Comparison of two rapid latex agglutination tests for detection of cryptococcal capsular polysaccharide.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Review: cell wall assembly in yeast

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Evaluation of a newly developed down-flow immunoassay for detection of serum mannan antigens in patients with candidaemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Advances and prospects for molecular diagnostics of fungal infections.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Aspergillus PCR: one step closer to standardization.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Galactomannan in Bronchoalveolar Lavage Fluid

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

21 January 2018

Galactomannan detection for invasive aspergillosis in immunocompromized patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the significance of an isolated positive cryptococcal antigen in the cerebrospinal fluid of cancer patients?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Nature ofCandida albicans-derived carbohydrate antigen recognized by a monoclonal antibody in patient sera and distribution overCandidaspecies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined detection of mannanaemia and anti-mannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2011.178

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37934487&oldid=2201089703"